CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Accounting Officer sold 12,300 shares at $30.20 ($371,504)
- 4 Open-market sale Director sold 77,400 shares at $30.24 ($2,340,646)
- 4 Open-market sale Exec. VP, European Commercial sold 115,468 shares at $28.68 ($3,311,126)
- 4 Open-market sale Sabag Mark sold 216,892 shares at an average $28.73 ($6,230,754)
- 4 Exercise or conversion Director acquired 4,804 shares (option exercise)
- 4 Open-market sale Director sold 50,000 shares at $26.03 ($1,301,505)
- 4 Planned sale EVP, Head of U.S. Commercial sold 28,229 shares at $24.78 ($699,523)
- 4 Open-market sale EVP, Head of U.S. Commercial sold 30,000 shares at $25.11 ($753,321)
- 4 Open-market sale Director sold 200,000 shares at $24.11 ($4,821,880)
- 4 Open-market sale Chief Accounting Officer sold 12,300 shares at $24.44 ($300,564)
- 4 Open-market buy EVP, Chief Legal Officer bought 1,113 shares at $18.86 ($20,988)
- 4 Open-market sale Jover Placid sold 6,053 shares at $15.16 ($91,748)
- 4 Planned sale Hughes Eric A sold 52,742 shares at $15.16 ($799,437)
- 4 Planned sale EVP, Chief Financial Officer sold 55,775 shares at $17.08 ($952,464)
- 4 Exercise or conversion Director acquired 9,632 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,632 shares (option exercise)
Page 5 of 34 · 666 filings